Multi-database analysis showed that genes associated with inflammatory response are important for prognosis prediction of renal clear cell carcinoma

Author:

Xiao Yonggui1,Xu Danping2,Jiang Chonghao3,Li Hubo1,Liu Jinzheng1,Huili Youlong1,Nie Shiwen1,Cao Fenghong3,Guan Xiaohai3

Affiliation:

1. North China University of Science and Technology

2. University of Electronic Science and Technology of China

3. Affiliated Hospital of North China University of Science and Technology

Abstract

Abstract Background Clear cell carcinoma of the kidney is the largest subtype of kidney tumor. Inflammatory responses are involved in all stages of the tumor. The relationship between genes related to inflammatory response and renal clear cell carcinoma is expected to help the diagnosis and treatment of tumor patients. Methods First, we obtained all the data needed for this study free of charge from a public database. After differential analysis and COX regression, we obtained genes that were used to build the model. In addition, data from multiple databases were included in this study. To make the data from different sources comparable, we standardize all the data using the SVA package. Next, through LASSO regression, we constructed a prognostic model of genes related to inflammation (IRGM). The model contains 10 gene model signatures related to the inflammatory response (IRGMS). The data used for modeling and internal validation came from the TCGA database and the GSE29609 dataset. Clear cell renal carcinoma data from the ICGC database will be used for external validation. Tumor data from E-MTAB-1980 cohort will provide an additional external validation. The GSE40453 dataset and the GSE53757 dataset will be used to verify the differential expression of IRGMS. The immunohistochemistry of IRGMS will be queried through the HPA database. After adequate validation of IRGM, we explored the application of IRGM in greater depth by constructing nomograms, pathway enrichment analysis, immunocorrelation analysis, drug susceptibility analysis, and subtype identification. Results IRGM can robustly predict the prognosis of patient samples with clear cell carcinoma of the kidney from different databases. IRGMS (IGFBP3, SCNN1B, IFI16, LRRC19, GSTM3, IFI44, APOLD1, HPGD, CPA3, PROM1) is expected to become a new biomarker associated with clear cell carcinoma of the kidney. The construction of nomogram can use IRGM to predict patient survival more accurately, so as to adopt more reasonable treatment methods. Pathway enrichment analysis showed that patients in the HR group were associated with a variety of tumorigenesis biological processes. Immune-related analysis and drug susceptibility analysis suggest that patients with higher IRGM scores have more treatment options. The subtype identification results are conducive to further refinement of treatment. Conclusion IRGMS (IGFBP3, SCNN1B, IFI16, LRRC19, GSTM3, IFI44, APOLD1, HPGD, CPA3, PROM1) is valuable in predicting the prognosis of clear cell carcinoma of the kidney. Patients with higher IRGM scores may be better candidates for treatment with immune checkpoint inhibitors and have more chemotherapy options.

Publisher

Research Square Platform LLC

Reference41 articles.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3